Journal Article Summary
The article examines the financial advantages of investing in quality improvements in pharmaceutical manufacturing, specifically focusing on a Nigerian company, Chi Pharmaceuticals Limited. The importance of this topic lies in the need for local pharmaceutical industries in Africa to comply with international Good Manufacturing Practices (GMP) to ensure the production of high-quality medicines. This is crucial for improving health outcomes, as many African countries struggle with access to safe and effective medications, often relying heavily on imported drugs, which can be costly and unreliable.
To assess the cost-benefit of achieving WHO GMP certification, the study analyzed the resources Chi Pharmaceuticals invested over four years to enhance its facilities and systems for producing zinc sulfate 20-mg dispersible tablets. The researchers calculated a benefit-cost ratio (BCR) of 5.3, indicating that the financial benefits of quality improvements significantly outweighed the costs. This means that for every dollar spent on quality enhancements, the company could expect to gain over five dollars in return, highlighting the economic viability of such investments.
However, the study has limitations, as it is based on a single company's experience, which may not be representative of all local manufacturers in Nigeria or Africa. Readers should consider discussing the implications of these findings with healthcare professionals, particularly regarding the importance of quality in pharmaceuticals and the potential benefits of supporting local manufacturers. Additionally, it is vital to recognize the challenges faced by these companies, such as financial constraints and regulatory hurdles, which can impact their ability to invest in quality improvements.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Anyakora Chimezie, Ekwunife Obinna, Alozie Faith, Esuga Mopa, Ukwuru Jonathan, Onya Steve, Nwokike Jude. Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer. BMC Health Services Research 2017. DOI: 10.1186/s12913-017-2610-8. PMID: 28923044. PMCID: PMC5604295.
Featured Pill Pals Product
Acetaminophen 500 MG Caplets ---1,000 Count --- Generic For Tylenol --- Major / Rugby --- Over The Counter
Acetaminophen 500 MG Caplets —1,000 Count — Generic For Tylenol — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
